Irena Oblak

1.4k total citations
46 papers, 681 citations indexed

About

Irena Oblak is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Irena Oblak has authored 46 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 31 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Irena Oblak's work include Colorectal and Anal Carcinomas (19 papers), Colorectal Cancer Surgical Treatments (17 papers) and Gastric Cancer Management and Outcomes (10 papers). Irena Oblak is often cited by papers focused on Colorectal and Anal Carcinomas (19 papers), Colorectal Cancer Surgical Treatments (17 papers) and Gastric Cancer Management and Outcomes (10 papers). Irena Oblak collaborates with scholars based in Slovenia, Germany and United States. Irena Oblak's co-authors include Vaneja Velenik, Franc Anderluh, Primož Strojan, Janja Ocvirk, Barbara Šegedin, Lojze Šmid, Branko Zakotnik, Liesa Dziggel, Dirk Rades and Steven E. Schild and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Irena Oblak

44 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irena Oblak Slovenia 17 416 344 227 71 61 46 681
Laura L. Fernandes United States 10 369 0.9× 173 0.5× 149 0.7× 39 0.5× 58 1.0× 39 632
Virginia Osborn United States 13 236 0.6× 235 0.7× 124 0.5× 87 1.2× 38 0.6× 35 452
Puja Venkat United States 11 383 0.9× 193 0.6× 264 1.2× 105 1.5× 48 0.8× 36 744
Lionel Duck Belgium 11 490 1.2× 313 0.9× 279 1.2× 64 0.9× 47 0.8× 33 837
Astrid Dalhaug Norway 16 386 0.9× 212 0.6× 435 1.9× 24 0.3× 41 0.7× 70 715
A. Brewster United Kingdom 16 587 1.4× 414 1.2× 499 2.2× 41 0.6× 81 1.3× 33 1.2k
Todd A. Pezzi United States 15 280 0.7× 114 0.3× 271 1.2× 34 0.5× 72 1.2× 37 566
Mei‐Chin Hsieh United States 16 476 1.1× 164 0.5× 318 1.4× 37 0.5× 128 2.1× 64 832
Vishal Rana United States 11 412 1.0× 249 0.7× 271 1.2× 35 0.5× 114 1.9× 18 695
Tobin J. Strom United States 15 456 1.1× 251 0.7× 427 1.9× 192 2.7× 137 2.2× 30 807

Countries citing papers authored by Irena Oblak

Since Specialization
Citations

This map shows the geographic impact of Irena Oblak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Oblak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Oblak more than expected).

Fields of papers citing papers by Irena Oblak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Oblak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Oblak. The network helps show where Irena Oblak may publish in the future.

Co-authorship network of co-authors of Irena Oblak

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Oblak. A scholar is included among the top collaborators of Irena Oblak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Oblak. Irena Oblak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Žagar, Tina, et al.. (2022). Impact of the COVID-19 epidemic on cancer burden and cancer care in Slovenia: a follow-up study. Radiology and Oncology. 56(4). 488–500. 5 indexed citations
2.
Zadnik, Vesna, et al.. (2020). Impact of COVID-19 on cancer diagnosis and management in Slovenia – preliminary results. Radiology and Oncology. 54(3). 329–334. 51 indexed citations
3.
4.
Anderluh, Franc, et al.. (2019). Definitive radiochemotherapy in esophageal cancer - a single institution experience. Radiology and Oncology. 53(4). 480–487. 2 indexed citations
5.
Brecelj, Erik, Mirko Omejc, Franc Anderluh, et al.. (2019). Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia. Radiology and Oncology. 53(4). 465–472. 9 indexed citations
6.
Velenik, Vaneja, Janja Ocvirk, Erik Brecelj, et al.. (2019). Total neoadjuvant treatment of “ugly” rectal cancers in Slovenia. Annals of Oncology. 30. iv34–iv34.
7.
But-Hadžić, Jasna, Franc Anderluh, Erik Brecelj, et al.. (2018). Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial. Radiology and Oncology. 52(3). 267–274. 17 indexed citations
8.
Ratoša, Ivica, et al.. (2018). Breast size impact on adjuvant radiotherapy adverse effects and dose parameters in treatment planning. Radiology and Oncology. 52(3). 233–244. 25 indexed citations
9.
10.
Perpar, Ana, Erik Brecelj, Nada Rotovnik Kozjek, et al.. (2014). Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment. Radiology and Oncology. 49(2). 181–184. 2 indexed citations
11.
Oblak, Irena, et al.. (2013). Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma. Radiology and Oncology. 48(2). 189–196. 5 indexed citations
12.
Rades, Dirk, Liesa Dziggel, Barbara Šegedin, et al.. (2013). A simple survival score for patients with brain metastases from breast cancer. Strahlentherapie und Onkologie. 189(8). 664–667. 15 indexed citations
13.
Oblak, Irena, et al.. (2012). Long term outcome after combined modality treatment for anal cancer. Radiology and Oncology. 46(2). 145–52. 23 indexed citations
14.
Oblak, Irena, et al.. (2011). Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III. Radiology and Oncology. 45(3). 209–12. 5 indexed citations
15.
Oblak, Irena, et al.. (2009). Anal cancer chemoirradiation with curative intent – a single institution experience. Neoplasma. 56(2). 150–155. 6 indexed citations
16.
Velenik, Vaneja, Janja Ocvirk, Irena Oblak, & Franc Anderluh. (2009). A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer. European Journal of Surgical Oncology. 36(3). 244–250. 40 indexed citations
17.
Oblak, Irena, Vaneja Velenik, Franc Anderluh, & Primož Strojan. (2007). Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia. European Journal of Surgical Oncology. 33(8). 982–987. 8 indexed citations
18.
Velenik, Vaneja, et al.. (2005). Managing anemia with epoetin alfa in patients with rectal cancer. Radiology and Oncology. 39(2). 2 indexed citations
19.
Strojan, Primož, Irena Oblak, Branka Svetic, Lojze Šmid, & Janko Kos. (2004). Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis. British Journal of Cancer. 90(10). 1961–1968. 34 indexed citations
20.
Šmid, Lojze, Marjan Budihna, Branko Zakotnik, et al.. (2003). Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1055–1062. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura L. Fernandes Breakdown of academic impact, for papers by Virginia Osborn Breakdown of academic impact, for papers by Puja Venkat Breakdown of academic impact, for papers by Lionel Duck Breakdown of academic impact, for papers by Astrid Dalhaug Breakdown of academic impact, for papers by A. Brewster Breakdown of academic impact, for papers by Todd A. Pezzi Breakdown of academic impact, for papers by Mei‐Chin Hsieh Breakdown of academic impact, for papers by Vishal Rana Breakdown of academic impact, for papers by Tobin J. Strom
Rankless by CCL
2026